These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37631877)

  • 21. Vaccination with Formulation of Nanoparticles Loaded with Leishmania amazonensis Antigens Confers Protection against Experimental Visceral Leishmaniasis in Hamster.
    González MAC; Gonçalves AAM; Ottino J; Leite JC; Resende LA; Melo-Júnior OA; Silveira P; Cardoso MS; Fujiwara RT; Bueno LL; Santos RL; Carvalho TF; Garcia GM; Paes PRO; Galdino AS; Chávez-Fumagalli MA; Melo MM; Silveira-Lemos D; Martins-Filho OA; Dutra WO; Mosqueira VCF; Giunchetti RC
    Vaccines (Basel); 2023 Jan; 11(1):. PubMed ID: 36679956
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c mice.
    Danesh-Bahreini MA; Shokri J; Samiei A; Kamali-Sarvestani E; Barzegar-Jalali M; Mohammadi-Samani S
    Int J Nanomedicine; 2011; 6():835-42. PubMed ID: 21589651
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chimeric vaccine combined with adjuvant system induces immunogenicity and protection against visceral leishmaniasis in BALB/c mice.
    Ostolin TLVDP; Gusmão MR; Mathias FAS; Cardoso JMO; Roatt BM; Aguiar-Soares RDO; Ruiz JC; Resende DM; de Brito RCF; Reis AB
    Vaccine; 2021 May; 39(20):2755-2763. PubMed ID: 33875268
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of an immunogen containing CD4
    de Andrade Ferraz I; Carvalho AMRS; de Brito RCF; Roatt BM; Martins VT; Lage DP; Dos Reis Cruz L; Medeiros FAC; Gonçalves DU; da Costa Rocha MO; Coelho EAF; de Oliveira Mendes TA; Duarte MC; Menezes-Souza D
    Appl Microbiol Biotechnol; 2022 Jun; 106(12):4627-4641. PubMed ID: 35759035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
    Das P; Paik D; Naskar K; Chakraborti T
    Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.
    Jain V; Gupta A; Pawar VK; Asthana S; Jaiswal AK; Dube A; Chourasia MK
    Appl Biochem Biotechnol; 2014 Oct; 174(4):1309-1330. PubMed ID: 25106894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination using live attenuated Leishmania donovani centrin deleted parasites induces protection in dogs against Leishmania infantum.
    Fiuza JA; Gannavaram S; Santiago Hda C; Selvapandiyan A; Souza DM; Passos LS; de Mendonça LZ; Lemos-Giunchetti Dda S; Ricci ND; Bartholomeu DC; Giunchetti RC; Bueno LL; Correa-Oliveira R; Nakhasi HL; Fujiwara RT
    Vaccine; 2015 Jan; 33(2):280-8. PubMed ID: 25475955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.
    Aguiar-Soares RD; Roatt BM; Ker HG; Moreira Nd; Mathias FA; Cardoso JM; Gontijo NF; Bruna-Romero O; Teixeira-Carvalho A; Martins-Filho OA; Corrêa-Oliveira R; Giunchetti RC; Reis AB
    Parasit Vectors; 2014 Feb; 7():61. PubMed ID: 24507702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanism of Anti-Cancer Activity of Benomyl Loaded Nanoparticles in Multidrug Resistant Cancer Cells.
    Kini S; Bahadur D; Panda D
    J Biomed Nanotechnol; 2015 May; 11(5):877-89. PubMed ID: 26349399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect on cellular recruitment and the innate immune response by combining saponin, monophosphoryl lipid-A and Incomplete Freund's Adjuvant with Leishmania (Viannia) braziliensis antigens for a vaccine formulation.
    Vitoriano-Souza J; Siqueira Mathias FA; Moreira NDD; Aguiar-Soares RDO; de Abreu Vieira PM; Teixeira-Carvalho A; Carneiro CM; Giunchetti RC; de Brito RCF; Fujiwara RT; Roatt BM; Melo MN; Reis AB
    Vaccine; 2019 Nov; 37(49):7269-7279. PubMed ID: 31575491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acylation-dependent and-independent membrane targeting and distinct functions of small myristoylated proteins (SMPs) in Leishmania major.
    Tull D; Heng J; Gooley PR; Naderer T; McConville MJ
    Int J Parasitol; 2012; 42(3):239-47. PubMed ID: 22281304
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.
    Roatt BM; Aguiar-Soares RD; Vitoriano-Souza J; Coura-Vital W; Braga SL; Corrêa-Oliveira R; Martins-Filho OA; Teixeira-Carvalho A; de Lana M; Figueiredo Gontijo N; Marques MJ; Giunchetti RC; Reis AB
    PLoS One; 2012; 7(11):e49780. PubMed ID: 23189161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
    Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
    Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs.
    Giunchetti RC; Corrêa-Oliveira R; Martins-Filho OA; Teixeira-Carvalho A; Roatt BM; de Oliveira Aguiar-Soares RD; Coura-Vital W; de Abreu RT; Malaquias LC; Gontijo NF; Brodskyn C; de Oliveira CI; Costa DJ; de Lana M; Reis AB
    Vaccine; 2008 Jan; 26(5):623-38. PubMed ID: 18180079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis.
    Thakur A; Kaur H; Kaur S
    Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell recruitment and cytokines in skin mice sensitized with the vaccine adjuvants: saponin, incomplete Freund's adjuvant, and monophosphoryl lipid A.
    Vitoriano-Souza J; Moreira Nd; Teixeira-Carvalho A; Carneiro CM; Siqueira FA; Vieira PM; Giunchetti RC; Moura SA; Fujiwara RT; Melo MN; Reis AB
    PLoS One; 2012; 7(7):e40745. PubMed ID: 22829882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of Potential CD4
    E Silva RF; de Oliveira BC; da Silva AA; Brelaz de Castro MCA; Ferreira LFGR; Hernandes MZ; de Brito MEF; de-Melo-Neto OP; Rezende AM; Pereira VRA
    Front Immunol; 2019; 10():3145. PubMed ID: 32117204
    [No Abstract]   [Full Text] [Related]  

  • 39. Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.
    Ataman-Onal Y; Munier S; Ganée A; Terrat C; Durand PY; Battail N; Martinon F; Le Grand R; Charles MH; Delair T; Verrier B
    J Control Release; 2006 May; 112(2):175-85. PubMed ID: 16563545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chitosan Nanoparticles Loaded with Whole and Soluble Leishmania Antigens, and Evaluation of Their Immunogenecity in a Mouse Model of Leishmaniasis.
    Hojatizade M; Soleymani M; Tafaghodi M; Badiee A; Chavoshian O; Jaafari MR
    Iran J Immunol; 2018 Dec; 15(4):281-293. PubMed ID: 30593742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.